Semaglutide, originally developed by Novo Nordisk, is a GLP-1 receptor agonist used in the management of Type 2 diabetes and weight control
Adopt a balanced, nutrient-rich diet that includes plenty of fruits, vegetables, lean proteins, and whole grains
While ferroptosis and gut dysbiosis have been extensively studied in isolation, growing evidence supports profound molecular crosstalk between these pathways, which synergistically drive OA progression
Supported by lifestyle improvements like diet and exercise, semaglutide offers the opportunity for sustainable weight loss and healthier living
The combination of GLP-1 medications with hormone therapy further enhances weight loss outcomes, particularly for women experiencing the challenges of menopause
It consists of 29 amino acids [29] and its gene is located on chromosome 2 [30]